Pages
Ads
Categories
- Allergies pills
- Anthelmintics
- Anti Convulsants Pills
- Anti Depressants Pills
- Antibiotics Pills
- AntiViralPill
- Arthritis pills
- Blood Pressure Pills
- Cholesterol Pills
- Diabetes Pills
- Diuretics pills
- eBook download
- Erectile Dysfunction Pills
- Gastrointestinal Pills
- Heartburn Pills
- herbal
- Hypertension pills
- Images pills
- Inflammatory
- Mens Health pills
- Muscle Relaxant Pills
- News
- Other pills
- Pain Relief Pills
- Review prices
- Skin Care Pills
- Stop Smoking Pills
- Uncategorized
- Video about ED pills
- Weight Loss Pills
- Women's Health Drugs
Blogroll
- Acomplia blog
- Advanced whois
- Buy Generic Zofran (Ondansetron)
- Buy Pills Online
- Cialis vs Levitra
- Diet Recipes Blog
- Flexyx A-Z drugs
- Generic Cialis soft tabs
- German drugstore
- Health News and Articles
- Health Signal
- Home Health Agencies
- Italian drugstore
- Natural Weight Loss
- Net Pharmacy
- Spanish drugstore
- The Canadian Rx Drugs
- Traumatology and Orthopaedics
- Viagra Mastercard
- Viagra Without Prescription
- FDA Approves Bayer HealthCare's Kogenate FS Treatment for Routine Prophylaxis in Children with Hemophilia A
- FDA Approves AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipolar Mania in the US
- FDA Approves New Injection Site for Risperdal Consta for Schizophrenia Treatment
- Watson Receives US FDA Approval for Rapaflo (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
- Akorn, Inc. Announces the FDA Approval of Akten Ophthalmic Gel 3.5%
- U.S. Food & Drug Administration Approved the use of Reyataz (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
- FDA Grants Lilly's Alimta (Pemetrexed for Injection) Third U.S. Approval
- Boston Scientific Announces FDA Approval of TAXUS Express2 Atom Stent System, First Drug-Eluting Stent For Small Vessels
- Teva's ProAir HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication
- FDA Approves Nasacort AQ Nasal Spray for Children Aged 2-5 years old
Tags
ads
The First Miracle Drugs
May 11, 2008
On Christmas Day 1932, the German chemical combine I.G. Farbenindustrie
filed a patent application on behalf of a red dye that its medical researchers
and chemists had found to have a remarkable ability to cure certain kinds of bac-
terial infections in mice. By the time the patent was awarded just over two years
later, the dye, now called by the trade name Prontosil, had been found to have the
same curative powers in humans. Announced in a brief publication in a German
medical journal in February 1935 by Gerhard Domagk, the medical researcher re-
sponsible for the work, Prontosil went on the market and became available to doc-
tors in April 1935.
In retrospect, it is clear that the introduction of Prontosil marked a turning
point in the history of medicine. As the first of the compounds called sulfon-
amides or, more familiarly, sulfa drugs, Prontosil initiated a revolution in the ther-
apeutics and management of bacterial infections. Within a few years, feared
diseases such as streptococcal infections (including childbed fever and sep-
ticemia), pneumonia, meningitis, dysentery, gonorrhea, and urinary tract infec-
tions, were brought under a substantial measure of control by chemotherapy. The
medical success of the sulfa drugs gave a powerful impetus to the expansion of the
international pharmaceutical industry and of the research and development enter-
prise within it….
Posted in: eBook download | |
No Comments »
No comments yet.
Fatal error: Call to undefined function: post_comments_feed_link() in /usr/home/drugrxus/domains/drugrxus.com/public_html/news/wp-content/themes/apple/comments.php on line 29